| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T83 |
0-19 |
Sentence |
denotes |
Further information |
| T84 |
20-97 |
Sentence |
denotes |
ASCO coronavirus resources: https://www.asco.org/asco-coronavirus-information |
| T85 |
98-315 |
Sentence |
denotes |
Clinical guide for the management of cancer patients during the coronavirus pandemic: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/specialty-guide-acute-treatment-cancer-23-march-2020.pdf |
| T86 |
316-386 |
Sentence |
denotes |
COVID-19 and cancer: https://www.esmo.org/newsroom/covid-19-and-cancer |
| T87 |
387-577 |
Sentence |
denotes |
COVID-19 clinical oncology frequently asked questions (FAQs): https://www.asco.org/sites/new-www.asco.org/files/content-files/blog-release/pdf/COVID-19-Clinical%20Oncology-FAQs-3-12-2020.pdf |
| T88 |
578-713 |
Sentence |
denotes |
COVID-19 recommendations to radiation oncology practices: https://www.astro.org/Daily-Practice/COVID-19-Recommendations-and-Information |
| T89 |
714-895 |
Sentence |
denotes |
Pandemic planning clinical guideline for patients with cancer: https://www.obgyn.utoronto.ca/sites/default/files/oh-cco_pandemic_planning_clinical_guideline_final_2020-03-10_002.pdf |
| T90 |
896-1035 |
Sentence |
denotes |
“Radiotherapy in a time of crisis”, ESTRO Presidents’ statement: https://www.estro.org/About/Newsroom/News/Radiotherapy-in-a-time-of-crisis |
| T91 |
1037-1053 |
Sentence |
denotes |
Acknowledgements |
| T92 |
1054-1091 |
Sentence |
denotes |
The authors gratefully acknowledge S. |
| T93 |
1092-1104 |
Sentence |
denotes |
Berry and M. |
| T94 |
1105-1138 |
Sentence |
denotes |
Brundage (Queen’s University), A. |
| T95 |
1139-1177 |
Sentence |
denotes |
Detsky (University of Toronto), and A. |
| T96 |
1178-1275 |
Sentence |
denotes |
Purushotham (King’s College London) for comments provided on an earlier draft of this manuscript. |
| T97 |
1276-1426 |
Sentence |
denotes |
We are also grateful to leaders and our clinical colleagues in the Department of Oncology at Queen’s University for input into the proposed framework. |
| T98 |
1427-1575 |
Sentence |
denotes |
T.P.H. holds a research chair provided by the Ontario Institute for Cancer Research through funding provided by the Government of Ontario (#IA-035). |
| T99 |
1576-1704 |
Sentence |
denotes |
C.M.B. is supported as the Canada Research Chair in Population Cancer Care through funding provided by the Government of Canada. |
| T100 |
1706-1725 |
Sentence |
denotes |
Competing interests |
| T101 |
1726-1769 |
Sentence |
denotes |
The authors declare no competing interests. |
